Safeguarding mitochondrial genomes in higher eukaryotes
Crossref DOI link: https://doi.org/10.1038/s41594-020-0474-9
Published Online: 2020-08-06
Published Print: 2020-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fu, Yi
Tigano, Marco
Sfeir, Agnel http://orcid.org/0000-0003-1633-8535
Text and Data Mining valid from 2020-08-01
Version of Record valid from 2020-08-01
Article History
Received: 24 February 2020
Accepted: 2 July 2020
First Online: 6 August 2020
Competing interests
: Agnel Sfeir is a cofounder, consultant and shareholder in Repare Therapeutics.